Venus Medtech still seeking cure for governance problems
The transcatheter maker’s shares were suspended last November, and it must still meet several conditions from the Hong Kong Stock Exchange before trading can resume Key Takeways: Venus Medtech disclosed…
Recent Articles
RELATED ARTICLES
-
No respite for RemeGen as problems and losses pile up
9995.HK 688331.SHG
